申请人:SNOW BRAND MILK PRODUCTS CO., LTD.
公开号:EP0855391A1
公开(公告)日:1998-07-29
Novel isoquinoline derivatives represented by general formula (I) or pharmaceutically acceptable acid-addition salts thereof, prepared by aiming at providing novel compounds which have an inhibitory activity on nerve cell death of the apoptosis type, wherein Ar represents an optionally substituted aromatic ring; and n is 0, 1 or 2. Because of the inhibitory effect on cell death, these compounds are useful as preventives and remedies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's chorea and amyotrophic lateral sclerosis, ischemic cerebral diseases such as cerebral stroke, and peripheral nerve disorders observed in diabetes, etc.
通式(I)代表的新型异喹啉衍生物或其药学上可接受的酸加成盐,旨在提供对神经细胞凋亡具有抑制活性的新型化合物,其中Ar代表任选取代的芳环;n为0、1或2。由于对细胞死亡具有抑制作用,这些化合物可作为预防和治疗神经退行性疾病(如阿尔茨海默病、帕金森病、亨廷顿舞蹈症和肌萎缩性脊髓侧索硬化症)、缺血性脑疾病(如脑中风)和糖尿病引起的周围神经紊乱等的药物。